Variable | T1 (baseline) | T2 (2–4 weeks) | T3 (6 months) | T4 (15 months) |
---|---|---|---|---|
Date of diagnosis | 17 (50%) | 23 (67.65%) | 18 (52.94%) | 7 (77.78%) |
Diagnosis | 32 (94.12%) | 25 (73.53%) | 21 (61.76%) | 7 (77.78%) |
Life expectancy from now | 15 (44.12%) | 8 (23.53%) | 9 (26.47%) | 1 (11.11%) |
Date of last clinic visit | 26 (76.47%) | 23 (67.65%) | 21 (61.76%) | 6 (66.67%) |
Current medication | 32 (94.12%) | 25 (73.53%) | 21 (61.76%) | 7 (77.78%) |
Change in symptoms | 31 (91.18%) | 23 (67.65%) | 16 (47.06%) | 6 (66.67%) |
What NYHA functional class is the patient now in | 32 (94.12%) | 24 (70.59%) | 20 (58.82%) | 7 (77.78%) |
Number who changed to functional class since last visit | 29 (85.29%) | 23 (67.65%) | 19 (55.88%) | 6 (66.67%) |
Patient’s medication has changed since last visit? | 29 (85.29%) | 25 (73.53%) | 20 (58.82%) | 7 (77.78%) |
Change given (of those who changed medication) | 4 (100%) | 8 (88.89%) | 9 (100%) | Â |
Reasons given (of those who changed medication) | 3 (75%) | 8 (88.89%) | 8 (88.89%) | Â |
Opinion of whether patient is better, the same or worse | 21 (61.76%) | 19 (55.88%) | 16 (47.06%) | 4 (44.44%) |
6-min walk | 19 (55.8%) | 12 (35.3%) | 14 (41.1%) | 4 |
Echocardiogram | 19 (55.8%) | 15 (44.1%) | 13 (38.2%) | 3 |
ECG | 16 (47.1%) | 14 (41.1%) | 15 (44.1%) | 4 |
SF-36 score | ||||
 SF-36 PCS | 91.2% (31/34) | 67.6% (23/34) | 52.9% (18/34) | 77.8% (7/9) |
 SF-36 MCS | 91.2% (31/34) | 67.6% (23/34) | 55.9% (19/34) | 77.8% (7/9) |
 SF-6D | 88.2% (30/34) | 67.6% (23/34) | 52.9% (18/34) | 66.7% (6/9) |
 BAI | 85.3% (29/34) | 67.6% (23/34) | 61.9% (21/34) | 77.8% (7/9) |
 BDI | 91.2% (31/34) | 67.6% (23/34) | 58.8% (20/34) | 77.8% (7/9) |